We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
+17.67%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.6B
Cap. Flow
+$186M
Cap. Flow %
1.65%
Top 10 Hldgs %
53.18%
Holding
660
New
44
Increased
183
Reduced
381
Closed
52

Sector Composition

Rank Sector Weight
1 Energy 69.1%
2 Materials 2.16%
3 Healthcare 1.94%
4 Financials 1.94%
5 Technology 1.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCUL icon
601
Ocular Therapeutix
OCUL
$1.86B
$172K ﹤0.01%
34,792
+6,976
+25% +$69.1K
OPK icon
602
Opko Health
OPK
$921M
$159K ﹤0.01%
+17,001
New +$173K
S
603
DELISTED
Sprint Corporation
S
$140K ﹤0.01%
30,795
+19,369
+170% +$71.7K
INFI
604
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$92K ﹤0.01%
+69,463
New +$325K
SRRA
605
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$84K ﹤0.01%
1,060
+215
+25% +$41K
ODP
606
DELISTED
ODP
ODP
$46K ﹤0.01%
+1,379
New +$67.3K
GRPN icon
607
Groupon
GRPN
$980M
$45K ﹤0.01%
+687
New +$50.8K
GNW icon
608
Genworth Financial
GNW
$3.8B
$39K ﹤0.01%
15,028
+1,859
+14% +$6.01K
AFMD
609
DELISTED
Affimed
AFMD
-3,740
Closed -$140K
AGG icon
610
iShares Core US Aggregate Bond ETF
AGG
$138B
-80,515
Closed -$8.93M
ASND icon
611
Ascendis Pharma A/S
ASND
$16.7B
-28,259
Closed -$524K
BCRX icon
612
BioCryst Pharmaceuticals
BCRX
$2.37B
-82,476
Closed -$233K
BN icon
613
Brookfield
BN
$102B
-3,980,089
Closed -$48.6M
BVN icon
614
Compañía de Minas Buenaventura
BVN
$7.85B
-87,446
Closed -$644K
CBRL icon
615
Cracker Barrel
CBRL
$1.2B
-2,881
Closed -$440K
CMI icon
616
Cummins
CMI
$91.7B
-210,384
Closed -$23.1M
COLM icon
617
Columbia Sportswear
COLM
$3.19B
-7,078
Closed -$425K
CPRT icon
618
Copart
CPRT
$25.9B
-84,336
Closed -$430K
DBI icon
619
Designer Brands
DBI
$277M
-15,058
Closed -$416K
DHR icon
620
Danaher
DHR
$135B
-600,284
Closed -$38.3M
DVAX
621
DELISTED
Dynavax Technologies
DVAX
-43,213
Closed -$831K
EC icon
622
Ecopetrol
EC
$32.9B
-25,082
Closed -$216K
EGO icon
623
Eldorado Gold
EGO
$8.31B
-351,586
Closed -$5.55M
ELDN icon
624
Eledon Pharmaceuticals
ELDN
$276M
-157
Closed -$142K
FNV icon
625
Franco-Nevada
FNV
$41.4B
-393,556
Closed -$24.2M

Similar funds

ALPS Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ALPS Advisors held 660 positions worth $11.3B, up 17% from $9.68B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

ALPS Advisors's Q2 2016 filing shows 44 new, 183 increased, 381 reduced and 52 closed positions. Its largest new stake was NGL Energy Partners: 5,895,930 shares worth $114M. The largest sale was Energy Transfer Partners L.p., an estimated $88.3M.

By sector, the portfolio is most concentrated in Energy at 69% of assets, up from 67% a quarter earlier, followed by Materials and Healthcare.

  • ALPS Advisors's largest Q2 2016 buy was NGL Energy Partners: 5,895,930 shares worth $114M.
  • ALPS Advisors added most to Magellan Midstream Partners, L.P. in Q2 2016, an estimated $132M increase.
  • ALPS Advisors's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $88.3M.
  • ALPS Advisors fully exited Brookfield in Q2 2016, selling an estimated $48.6M.
  • ALPS Advisors's ten largest holdings make up 53% of its $11.3B portfolio in Q2 2016.
  • ALPS Advisors opened 44 new positions and closed 52 in Q2 2016.
  • ALPS Advisors's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on ALPS Advisors's 13F filing for Q2 2016, filed 27 Jul 2016.